<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(1)</volume><submitter>Ventura-Bixenshpaner H</submitter><pubmed_abstract>Acquired resistance to the estrogen receptor (ER) antagonist tamoxifen, is a major obstacle in treatment of breast cancer. Changes in Zn&lt;sup>2+&lt;/sup> accumulation and distribution are associated with tamoxifen-resistance and breast cancer progression. The Zn&lt;sup>2+&lt;/sup>-sensing G-protein coupled receptor, ZnR/GPR39, triggers signaling leading to cell growth, but a role for this receptor in breast cancer in unknown. Using fluorescence imaging, we found Zn&lt;sup>2+&lt;/sup>-dependent Ca&lt;sup>2+&lt;/sup> release, mediated by ZnR/GPR39 activity, in TAMR tamoxifen-resistant cells derived from MCF-7 cells, but not in ER-expressing MCF-7 or T47D cells. Furthermore, ZnR/GPR39 signaling was monitored in ER negative BT20, MDA-MB-453 and JIMT-1 cells. Expression of ZnR/GPR39 was increased in grade 3 human br</pubmed_abstract><journal>Scientific reports</journal><pagination>8119</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5970167</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Enhanced ZnR/GPR39 Activity in Breast Cancer, an Alternative Trigger of Signaling Leading to Cell Growth.</pubmed_title><pmcid>PMC5970167</pmcid><pubmed_authors>Sekler I</pubmed_authors><pubmed_authors>Elkabets M</pubmed_authors><pubmed_authors>Asraf H</pubmed_authors><pubmed_authors>Taylor KM</pubmed_authors><pubmed_authors>Ventura-Bixenshpaner H</pubmed_authors><pubmed_authors>Chakraborty M</pubmed_authors><pubmed_authors>Hershfinkel M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Enhanced ZnR/GPR39 Activity in Breast Cancer, an Alternative Trigger of Signaling Leading to Cell Growth.</name><description>Acquired resistance to the estrogen receptor (ER) antagonist tamoxifen, is a major obstacle in treatment of breast cancer. Changes in Zn&lt;sup>2+&lt;/sup> accumulation and distribution are associated with tamoxifen-resistance and breast cancer progression. The Zn&lt;sup>2+&lt;/sup>-sensing G-protein coupled receptor, ZnR/GPR39, triggers signaling leading to cell growth, but a role for this receptor in breast cancer in unknown. Using fluorescence imaging, we found Zn&lt;sup>2+&lt;/sup>-dependent Ca&lt;sup>2+&lt;/sup> release, mediated by ZnR/GPR39 activity, in TAMR tamoxifen-resistant cells derived from MCF-7 cells, but not in ER-expressing MCF-7 or T47D cells. Furthermore, ZnR/GPR39 signaling was monitored in ER negative BT20, MDA-MB-453 and JIMT-1 cells. Expression of ZnR/GPR39 was increased in grade 3 human br</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 May</publication><modification>2026-07-15T17:02:13.812Z</modification><creation>2019-03-26T23:39:30Z</creation></dates><accession>S-EPMC5970167</accession><cross_references><pubmed>29802348</pubmed><doi>10.1038/s41598-018-26459-5</doi></cross_references></HashMap>